197 related articles for article (PubMed ID: 17175700)
1. A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis.
Kochar DK; Saini G; Kochar SK; Sirohi P; Bumb RA; Mehta RD; Purohit SK
J Vector Borne Dis; 2006 Dec; 43(4):161-7. PubMed ID: 17175700
[TBL] [Abstract][Full Text] [Related]
2. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis.
Nassiri-Kashani M; Firooz A; Khamesipour A; Mojtahed F; Nilforoushzadeh M; Hejazi H; Bouzari N; Dowlati Y
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):80-3. PubMed ID: 15649196
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
Sadeghian G; Nilforoushzadeh MA
Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
[TBL] [Abstract][Full Text] [Related]
5. The role of rifampicin in the management of cutaneous leishmaniasis.
Kochar DK; Aseri S; Sharma BV; Bumb RA; Mehta RD; Purohit SK
QJM; 2000 Nov; 93(11):733-7. PubMed ID: 11077029
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study.
Momeni AZ; Jalayer T; Emamjomeh M; Bashardost N; Ghassemi RL; Meghdadi M; Javadi A; Aminjavaheri M
Arch Dermatol; 1996 Jul; 132(7):784-6. PubMed ID: 8678570
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.
Alrajhi AA; Ibrahim EA; De Vol EB; Khairat M; Faris RM; Maguire JH
N Engl J Med; 2002 Mar; 346(12):891-5. PubMed ID: 11907288
[TBL] [Abstract][Full Text] [Related]
8. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.
Almeida R; D'Oliveira A; Machado P; Bacellar O; Ko AI; de Jesus AR; Mobashery N; Brito Santos J; Carvalho EM
J Infect Dis; 1999 Nov; 180(5):1735-7. PubMed ID: 10515844
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR
Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
Sadeghian G; Nilfroushzadeh MA; Iraji F
Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R
Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002).
Al-Tawfiq JA; AbuKhamsin A
Int J Infect Dis; 2004 Jul; 8(4):244-50. PubMed ID: 15234329
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
[TBL] [Abstract][Full Text] [Related]
18. Artesunate plus sulfamethoxypyrazine/pyrimethamine for the treatment of cutaneous leishmaniasis: a double-blind, placebo-controlled clinical trial.
Adam I; Hagelnur AA
Int J Antimicrob Agents; 2009 Oct; 34(4):380-1. PubMed ID: 19409761
[No Abstract] [Full Text] [Related]
19. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
